Suzuki I am in the medical business for 40 years . Mitral valvular disease is a huge area but its a very complex valve. Edwards are spending big in this area as its the new frontier of expansion.Anteris are in bed with 4C but they had a problem or two but the concept of their valve was novel and exciting. All I was stating is that our best in class Adapt tissue will be a big winner for the future successful Mitral valve company. If WP sells the company in toto I would like that he takes the value of our adapt tissue for the mitral valve area into account and claim an extra $1b for shares holders.
Suzuki I am in the medical business for 40 years . Mitral...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.10 | $14.41 | $13.73 | $535.0K | 38.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 935 | $14.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.20 | 60 | 1 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |